Literature DB >> 23872307

Activated factor X signaling via protease-activated receptor 2 suppresses pro-inflammatory cytokine production from lipopolysaccharide-stimulated myeloid cells.

Eimear M Gleeson1, James S O'Donnell, Emily Hams, Fionnuala Ní Áinle, Bridget-Ann Kenny, Padraic G Fallon, Roger J S Preston.   

Abstract

Vitamin K-dependent proteases generated in response to vascular injury and infection enable fibrin clot formation, but also trigger distinct immuno-regulatory signaling pathways on myeloid cells. Factor Xa, a protease crucial for blood coagulation, also induces protease-activated, receptor-dependent cell signaling. Factor Xa can bind both monocytes and macrophages, but whether factor Xa-dependent signaling stimulates or suppresses myeloid cell cytokine production in response to Toll-like receptor activation is not known. In this study, exposure to factor Xa significantly impaired pro-inflammatory cytokine production from lipopolysaccharide-treated peripheral blood mononuclear cells, THP-1 monocytic cells and murine macrophages. Furthermore, factor Xa inhibited nuclear factor-kappa B activation in THP-1 reporter cells, requiring phosphatidylinositide 3-kinase activity for its anti-inflammatory effect. Active-site blockade, γ-carboxyglutamic acid domain truncation and a peptide mimic of the factor Xa inter-epidermal growth factor-like region prevented factor Xa inhibition of lipopolysaccharide-induced tumor necrosis factor-α release. In addition, factor Xa anti-inflammatory activity was markedly attenuated by the presence of an antagonist of protease-activated receptor 2, but not protease-activated receptor 1. The key role of protease-activated receptor 2 in eliciting factor Xa-dependent anti-inflammatory signaling on macrophages was further underscored by the inability of factor Xa to mediate inhibition of tumor necrosis factor-α and interleukin-6 release from murine bone marrow-derived protease-activated receptor 2-deficient macrophages. We also show for the first time that, in addition to protease-activated receptor 2, factor Xa requires a receptor-associated protein-sensitive low-density lipoprotein receptor to inhibit lipopolysaccharide-induced cytokine production. Collectively, the findings of this study support a novel function for factor Xa as an endogenous, receptor-associated protein-sensitive, protease-activated receptor 2-dependent regulator of myeloid cell pro-inflammatory cytokine production.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23872307      PMCID: PMC4007938          DOI: 10.3324/haematol.2013.086918

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  42 in total

1.  The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1.

Authors:  G J Zaman; E M Conway
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

2.  The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

Authors:  Chunzhang Cao; Yamei Gao; Yang Li; Toni M Antalis; Francis J Castellino; Li Zhang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

Review 3.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

4.  Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation.

Authors:  S A Reddy; J H Huang; W S Liao
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

5.  Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages.

Authors:  Quan M Nhu; Kari Ann Shirey; Meghan E Pennini; Jennifer Stiltz; Stefanie N Vogel
Journal:  Innate Immun       Date:  2011-01-14       Impact factor: 2.680

Review 6.  Factor X deficiency.

Authors:  Marzia Menegatti; Flora Peyvandi
Journal:  Semin Thromb Hemost       Date:  2009-07-13       Impact factor: 4.180

7.  Coagulation factor Xa cleaves protease-activated receptor-1 and mediates signaling dependent on binding to the endothelial protein C receptor.

Authors:  R A Schuepbach; M Riewald
Journal:  J Thromb Haemost       Date:  2009-11-06       Impact factor: 5.824

8.  Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells.

Authors:  Xia V Yang; Yajnavalka Banerjee; José A Fernández; Hiroshi Deguchi; Xiao Xu; Laurent O Mosnier; Rolf T Urbanus; Phillip G de Groot; Tara C White-Adams; Owen J T McCarty; John H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-30       Impact factor: 11.205

9.  Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation.

Authors:  Frank Niessen; Florence Schaffner; Christian Furlan-Freguia; Rafal Pawlinski; Gourab Bhattacharjee; Jerold Chun; Claudia K Derian; Patricia Andrade-Gordon; Hugh Rosen; Wolfram Ruf
Journal:  Nature       Date:  2008-02-27       Impact factor: 49.962

10.  A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X.

Authors:  S J Tai; R W Herzog; P Margaritis; V R Arruda; K Chu; J A Golden; P A Labosky; K A High
Journal:  J Thromb Haemost       Date:  2007-11-23       Impact factor: 5.824

View more
  8 in total

Review 1.  Multiple roles of the coagulation protease cascade during virus infection.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

2.  Monocytes maintain central nervous system homeostasis following helminth-induced inflammation.

Authors:  Jianya Peng; Chandler B Sy; John J Ponessa; Alexander D Lemenze; Christina M Hernandez; Juan M Inclan-Rico; Arman Sawhney; Hannah G Federman; Krupa Chavan; Vanessa Espinosa; Sergei V Kotenko; Amariliz Rivera; Mark C Siracusa
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-07       Impact factor: 12.779

Review 3.  Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management.

Authors:  E Donnellan; B Kevane; B R Healey Bird; F Ni Ainle
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

4.  Revisiting antithrombotic therapeutics; sculptin, a novel specific, competitive, reversible, scissile and tight binding inhibitor of thrombin.

Authors:  Asif Iqbal; Mauricio Barbugiani Goldfeder; Rafael Marques-Porto; Huma Asif; Jean Gabriel de Souza; Fernanda Faria; Ana Marisa Chudzinski-Tavassi
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

5.  Variation of PPARG Expression in Chemotherapy-Sensitive Patients of Hypopharyngeal Squamous Cell Carcinoma.

Authors:  Meng Lian; Yong Tao; Jiaming Chen; Xixi Shen; Lizhen Hou; Shaolong Cao; Jugao Fang
Journal:  PPAR Res       Date:  2021-05-17       Impact factor: 4.964

6.  Manipulation of tissue factor-mediated basal PAR-2 signalling on macrophages determines sensitivity for IFNγ responsiveness and significantly modifies the phenotype of murine DTH.

Authors:  Hannah Wilkinson; Hugh Leonard; Michael G Robson; Richard Smith; ElLi Tam; John H McVey; Daniel Kirckhofer; Daxin Chen; Anthony Dorling
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

7.  Activated protein C and PAR1-derived and PAR3-derived peptides are anti-inflammatory by suppressing macrophage NLRP3 inflammasomes.

Authors:  Laura D Healy; José A Fernández; Laurent O Mosnier; John H Griffin
Journal:  J Thromb Haemost       Date:  2020-12-07       Impact factor: 5.824

8.  Inhibition of Protease-Activated Receptor 1 Does not Affect Dendritic Homeostasis of Cultured Mouse Dentate Granule Cells.

Authors:  Gerlind Schuldt; Christos Galanis; Andreas Strehl; Meike Hick; Sabine Schiener; Maximilian Lenz; Thomas Deller; Nicola Maggio; Andreas Vlachos
Journal:  Front Neuroanat       Date:  2016-06-13       Impact factor: 3.856

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.